Brief: Ikena Oncology Presents Data Describing Indication Selection Methodology, Translational Data, Trial In Progress For IK-175
12/11/2021 12:16
Nov 12 (Reuters) - Ikena Oncology Inc IKNA.O :
* IKENA ONCOLOGY PRESENTS DATA AT SITC 36TH ANNUAL MEETING
DESCRIBING THE INDICATION SELECTION METHODOLOGY, TRANSLATIONAL
DATA, AND TRIAL IN PROGRESS FOR IK-175
Source text for Eikon: ID:nGNX17wSH0
Further company coverage: IKNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ImageneBio
See all newsU.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma
Brief: ImageneBio Inc - On Oct 23, Elects Not To Renew Agreement With Miragene - SEC Filing
ImageneBio Inc expected to post a loss of $1.56 a share - Earnings Preview
Brief: Ikena Oncology Announces Stockholder Approval Of Merger With Inmagene Biopharmaceuticals